Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

What Will It Take to Make Fluoroscopy Labs Safer?

Six major medical societies released a joint statement calling for mandatory implementation of enhanced radiation protection devices in fluoroscopy labs.

Machine Learning May Simplify Estimation of LDL Cholesterol

A machine learning-based equation may estimate low-density lipoprotein cholesterol as accurately as the widely validated Martin-Hopkins method while offering easier implementation for clinical care.

Oral PCSK9 Inhibitor Welcomed for Potential in Primary Care

The recent approval of enlicitide was seen as a boon for some clinical scenarios, although real-world impact remains to be seen.

Obesity Treatment Advances, but Access Gaps Persist

Obesity care is evolving fast, but experts at ICO 2026 warned that access to treatment, prevention strategies, and policy follow-through remain deeply uneven.

Finerenone Lowers Blood Pressure in HFmrEF or HFpEF

Finerenone produced sustained reductions in systolic BP and consistently reduced cardiovascular death and heart failure events across a broad BP spectrum in patients with HFmrEF or HFpEF.

OAC After AF Ablation Benefits High-Risk Patients

In patients with elevated stroke risk, continuing oral anticoagulation after atrial fibrillation ablation was associated with lower thromboembolic events, though bleeding risk remained elevated across all groups.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Latest News

Six major medical societies released a joint statement calling for mandatory implementation of enhanced radiation protection devices in fluoroscopy labs.

A machine learning-based equation may estimate low-density lipoprotein cholesterol as accurately as the widely validated Martin-Hopkins method while offering easier implementation for clinical care.

The recent approval of enlicitide was seen as a boon for some clinical scenarios, although real-world impact remains to be seen.

Obesity care is evolving fast, but experts at ICO 2026 warned that access to treatment, prevention strategies, and policy follow-through remain deeply uneven.

Finerenone produced sustained reductions in systolic BP and consistently reduced cardiovascular death and heart failure events across a broad BP spectrum in patients with HFmrEF or HFpEF.

In patients with elevated stroke risk, continuing oral anticoagulation after atrial fibrillation ablation was associated with lower thromboembolic events, though bleeding risk remained elevated across all groups.

News All Time

Adults Aged 75 or Older With MASLD Face Polypharmacy Burden

Among older adults with metabolic dysfunction-associated steatotic liver disease, those aged 75 years or older face a notable burden of polypharmacy.

AI Tool Flags Six Acute Abdominal Emergencies on CT

A deep learning system uses multiwindow encoding to classify and map six acute life-threatening abdominal emergencies on CT scans to a clinical nine-region grid.

5 Smarter Ways to Beat Medical Information Overload

Medical evidence continues to grow rapidly, and these five practical strategies help physicians prioritize high-quality research, use AI effectively, and stay current more efficiently.

Grumblings Over CKM Guideline Not Warranted, Experts Say

Experts push back against concerns of overmedicalization and confusing staging with the new AHA/ACC guideline on cardiovascular-kidney-metabolic syndrome.

Eleven New Molecular Targets Expand Treatment Options

Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.

Can Europe Keep Its Medicines Cool in 40 °C+ Summers?

As European heat waves shatter records, aging clinical infrastructure and lack of funding leave lifesaving, temperature-sensitive drugs vulnerable to degradation.

How to Prepare Patients for Exotic Travel: 10 Tips for GPs

From pretravel counseling to vaccinations, prophylaxis, and environmental precautions, here is how general practitioners can help travelers reduce risks before and during their trip.

Infections May Raise Long-Term Risk for Chronic Disease

Experts say infections are an underrecognized driver of chronic disease, with inflammation helping fuel cardiovascular, renal, and neurologic risks.

Coronary Microvascular Disease: Is There a Genetic Link?

A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.

T2D and Heart Failure: The Diagnosis Site Matters

The clinical profile of patients with type 2 diabetes and heart failure varies notably according to whether the diagnosis appears in primary care records or hospital discharge records.

NICE Recommends New Nonsteroidal MRA for Heart Failure

NICE has recommended a nonsteroidal mineralocorticoid receptor antagonist that decreases worsening heart failure events in adults with preserved or mildly reduced ejection fraction.

Updated Heart Failure Definition Loosens LVEF Cutoffs

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.

Anti-Aging Trend: Why Is Gen Z Embracing It?

Social media has fueled interest in anti-aging strategies, but evidence continues to support exercise and adequate sleep over NAD+ boosters and off-label metformin.

How Drones Could Reshape German Medicine

In rural emergencies and time-critical sample transport, drones may reach patients and labs faster than road teams — yet nationwide deployment remains far from assured.

Why Homeless Patients Still Struggle to See a GP

Homelessness in England has hit record levels, but digital barriers, registration hurdles, and funding gaps keep many patients locked out of primary care.

Hospitals Enter the Era of In-House 3D Manufacturing

A Spanish hospital’s new certification highlights how in-house 3D printing can support patient-specific devices, surgical planning, and faster clinical workflows.

Recommended News For You

Team finds broken 'brake' on cancer mutation machine.

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

New imaging solution could help improve survival for patients with recurring prostate cancer

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

The pathology of incurable cancers can be predicted thanks to research.

Recommended Articles For You

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer 

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Teaching Hematology Through Morphology-Based Learning 

From Bruises to Blood Clots: Everything You Need to Know about Hematoma  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

healthy despite having advanced cancer.

2.

Pressing the Sleep button could have a positive impact on cognition.

3.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

4.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

5.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

1.

Liquid Biopsies in Hematology: A Window into the Disease

2.

Early Recognition of Immune-Related Adverse Events During Cancer Therapy

3.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

4.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

5.

The importance of understanding normal serum osmolality

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

2.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

Updates on Standard V/S High Risk Myeloma Treatment

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot